UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000019021 |
|---|---|
| Receipt number | R000021582 |
| Scientific Title | effectiveness of intratympanic steroid injection for sudden sensorineural hearing loss |
| Date of disclosure of the study information | 2015/10/01 |
| Last modified on | 2015/10/02 19:37:42 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
effectiveness of intratympanic steroid injection for sudden sensorineural hearing loss
Acronym
effectiveness of intratympanic steroid injection for sudden sensorineural hearing loss
Scientific Title
effectiveness of intratympanic steroid injection for sudden sensorineural hearing loss
Scientific Title:Acronym
effectiveness of intratympanic steroid injection for sudden sensorineural hearing loss
Region
| Japan |
Condition
Condition
sudden sensorineural hearing loss
Classification by specialty
| Oto-rhino-laryngology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
1,effectiveness of tymanic steroid injection for salvage therapy
2,effectiveness of tymanic steroid injection for primary therapy
3,effectiveness of tymanic steroid injection for combination therapy
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
1,PTA 2 month after the therapy
2,SDS 2 month after the therapy
Key secondary outcomes
1,PTA 1 month,3 month and 6 month after the therapy
2,vertigo 1 month,2 month,3 month and 6 month after the therapy
3,tympanic menbrane perforaition 1 month,2 month,3 month and 6 month after the therapy
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
intratympanic steroid injection
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1,
2,
3,
Key exclusion criteria
1,
2,
3
4,
5,
6,
Target sample size
210
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Sho Kanzaki |
Organization
Keio university hospital
Division name
otorhinolaryngotogy
Zip code
Address
shinanomachi35 sinjukuku tokyo
TEL
03-3353-1211
skan@sc.itc.keio.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Sho Kanzaki |
Organization
Keio university hospital
Division name
otorhinolaryngotogy
Zip code
Address
shinanomachi35 sinjukuku tokyo
TEL
03-3353-1211
Homepage URL
skan@sc.itc.keio.ac.jp
Sponsor or person
Institute
Keio university otorhinolaryngotogy
Institute
Department
Personal name
Funding Source
Organization
Keio university otorhinolaryngotogy
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
慶應義塾大学病院
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 10 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2014 | Year | 10 | Month | 07 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 10 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2015 | Year | 09 | Month | 15 | Day |
Last modified on
| 2015 | Year | 10 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021582
